Find clinical trials for Lymphoma in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Durham, NC, USA:
The purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma...
Phase 2
Chapel Hill, North Carolina, United States of America and 2 other locations
Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly among people from the Caribbean islands, Western Africa, Brazil,...
Phase 2
Chapel Hill, North Carolina, United States and 3 other locations
and ibrutinib in patients with previously treated mantle cell lymphoma to evaluate the efficacy of this combination, with the primary object...
Phase 2
Chapel Hill, North Carolina, United States and 8 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
Durham, North Carolina, United States and 20 other locations
(R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma. However, single drug therapies have limitations, therefore, the current...
Phase 2
Durham, North Carolina, United States and 7 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Durham, North Carolina, United States and 59 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Durham, North Carolina, United States and 93 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Raleigh, North Carolina, United States and 215 other locations
comprise 2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in patients with primary central nervous system lymphoma...
Phase 1, Phase 2
Durham, North Carolina, United States and 41 other locations
safety, and tolerability BGB-3111 plus obinutuzumab versus obinutuzumab alone in participants with relapsed/refractory non-Hodgkin follicular lymphoma...
Phase 2
Durham, North Carolina, United States and 83 other locations
Clinical trials
Research sites
Resources
Legal